Fabio Di Piazza Selected Research

Prodigy

11/2022	Association Between Race and Opioid-Induced Respiratory Depression: An International Post Hoc Analysis of the Prediction of Opioid-induced Respiratory Depression In Patients Monitored by Capnography Trial.
1/2022	Nocturnal Oxygen Desaturation Index Correlates with Respiratory Depression in Post-Surgical Patients Receiving Opioids - A Post-Hoc Analysis from the Prediction of Opioid-Induced Respiratory Depression in Patients Monitored by Capnography (PRODIGY) Study.
6/2021	Postoperative opioid administration characteristics associated with opioid-induced respiratory depression: Results from the PRODIGY trial.
1/2021	Response to: Comment on: Postoperative opioid administration characteristics associated with opioid-induced respiratory depression: Results from the PRODIGY trial.
1/2021	Frequency and Temporal Distribution of Postoperative Respiratory Depressive Events.
1/2021	Modeling the Cost Savings of Continuous Pulse Oximetry and Capnography Monitoring of United States General Care Floor Patients Receiving Opioids Based on the PRODIGY Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fabio Di Piazza Research Topics

Disease

6	Respiratory Insufficiency (Respiratory Failure) 11/2022 - 01/2021
2	Apnea 01/2022 - 06/2021
1	Heart Failure 11/2022
1	Obesity 11/2022
1	Pain (Aches) 06/2021
1	Atrial Fibrillation 01/2021
1	Cardiac Arrhythmias (Arrythmia) 01/2021
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 06/2018
1	Hemorrhage 10/2014
1	Hemorrhagic Cystitis 10/2014
1	Hematologic Neoplasms (Hematological Malignancy) 10/2014
1	Sepsis (Septicemia) 11/2013
1	Infections 11/2013
1	Thrombosis (Thrombus) 11/2013
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2013

Drug/Important Bio-Agent (IBA)

6	ProdigyIBA 11/2022 - 01/2021
6	Opioid Analgesics (Opioids)IBA 11/2022 - 01/2021
1	Oxygen (Dioxygen)IBA 01/2022
1	Carbon DioxideIBA 01/2022
1	Oxyhemoglobins (Oxyhemoglobin)IBA 01/2022
1	Tramadol (K315)FDA LinkGeneric 06/2021
1	Anti-Arrhythmia AgentsIBA 01/2021
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 10/2014
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 11/2013

Therapy/Procedure

2	Therapeutics 01/2021 - 10/2014
2	Hematopoietic Stem Cell Transplantation 06/2018 - 10/2014
1	Length of Stay 01/2021
1	Catheter Ablation 01/2021
1	Homologous Transplantation 10/2014
1	Drug Therapy (Chemotherapy) 11/2013
1	Central Venous Catheters 11/2013